We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

New Capital Healthcare Disruptors Unhedged - Accumulation (GBP)

Sell:11,703.00p Buy:11,703.00p Change: 157.00p (1.36%)
Prices as at 23 October 2025
Sell:11,703.00p
Buy:11,703.00p
Change: 157.00p (1.36%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 23 October 2025
Sell:11,703.00p
Buy:11,703.00p
Change: 157.00p (1.36%)
Prices as at 23 October 2025
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 99.24%
Cash and Equiv. 0.76%

Top 10 holdings

Stock name % Weight Country Sector
1 ELI LILLY AND COMPANY 6.26% USA Pharmaceuticals & Biotechnology
2 DOXIMITY INC 5.36% USA Health Care Providers
3 ALNYLAM PHARMACEUTICALS 5.26% USA Pharmaceuticals & Biotechnology
4 ARGENX SE 4.93% NLD Pharmaceuticals & Biotechnology
5 HALOZYME THERAPEUTICS INC 4.77% USA Pharmaceuticals & Biotechnology
6 IDEXX LABORATORIES 4.74% USA Medical Equipment & Services
7 NATERA INC 4.65% USA Medical Equipment & Services
8 INSMED INCORPORATED 4.59% USA Pharmaceuticals & Biotechnology
9 VEEVA SYSTEMS 4.53% USA Health Care Providers
10 INTUITIVE SURGICAL 3.88% USA Medical Equipment & Services

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account